Atsushi Kambe

13PUBLICATIONS
13CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Aerodynamics (excl. hypersonic aerodynamics)Epidemiological modellingNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 28, 2026
Diffuse hemispheric glioma, H3 G34-mutant, in Simpson-Golabi-Behmel syndrome: the first reported case.

|Mar 11, 2026
Correction: Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.

Irfan Kesumayadi, Atsushi Kambe, Haruto Kanda

|Feb 05, 2026
Efficacy and safety profiles of single versus multiple pipeline embolization devices for intracranial aneurysms: a systematic review and meta-analysis.

Irfan Kesumayadi, Makoto Sakamoto, Hidefumi Amisaki

|Feb 01, 2026
Drug-induced hypertension is associated with improved survival in glioblastoma patients treated with bevacizumab: evidence from a time-to-event meta-analysis and meta-regression.

Irfan Kesumayadi, Atsushi Kambe, Hidefumi Amisaki

|Jan 10, 2026
Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.

Irfan Kesumayadi, Atsushi Kambe, Haruto Kanda

|Oct 23, 2025
Multidisciplinary Management of Plexiform Neurofibromas in Pediatric Patients With Neurofibromatosis 1: Insights From Advisory Board-Guided Clinical Experience in Japan.

Yuko Ehara, Tohru Okanishi, Yoshiko Suyama

Pageof 3

Frequent Collaborators

8 joint publications

Irfan Kesumayadi

7 joint publications

Makoto Sakamoto

6 joint publications

Masamichi Kurosaki

1 joint publications

Makoto Sakamoto